Ranch Capital Advisors’s AstraZeneca AZN Stock Holding History

Ranch Capital Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-614	Closed	-$74K	–	189
2021 Q3	$74K	Sell	614 -80	-12%	-$9.31K	0.05%	227
2021 Q2	$83K	Sell	694 -5,164	-88%	-$567K	0.05%	239
2021 Q1	$582K	Sell	5,858 -1,884	-24%	-$189K	0.38%	80
2020 Q4	$774K	Buy	7,742 +40	+0.5%	+$4.24K	0.56%	54
2020 Q3	$852K	Sell	7,702 -211	-3%	-$23.5K	0.68%	38
2020 Q2	$876K	Buy	+7,913	New	+$817K	0.69%	38

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ranch Capital Advisors's AZN Position: Q4 2021 in Review

Ranch Capital Advisors sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 614 shares — an estimated $74K sold.

Ranch Capital Advisors first reported a position in AZN in Q2 2020 and held it in 6 quarters. The position peaked at $876K in Q2 2020. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

Ranch Capital Advisors reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
Ranch Capital Advisors sold 614 AstraZeneca shares in Q4 2021, an estimated $74K.
Ranch Capital Advisors first reported a position in AstraZeneca in Q2 2020 and held it in 6 quarters.
Ranch Capital Advisors's AstraZeneca position peaked at $876K in Q2 2020.
949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Ranch Capital Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.